ISB News

Systems Biology + Systems Art

(Photo above: Artist Xiao Dong Feng and Dr. Lee Hood raise a toast during a reception on April 28. Feng’s painting “Qing Xu” hangs in the background. The name is symbolic of someone who eschews earthly materialism and is instead a visionary who seeks a higher or more spiritual understanding.)

On April 28, Institute for Systems Biology hosted an intimate symposium on Systems Biology & Systems Art in honor of special guest Xiao Dong Feng, who is a renowned painter in China. Dr. Lee Hood, president of ISB, is an enthusiastic art collector and had met Feng during a business trip to China.

“One of my pet theses has been, since the beginning, that the concepts that have emerged from systems approaches to biology are really generalizable to almost any profession,” Hood said during his introduction.

ISB hosted a symposium on systems biology and systems art, which featured several speakers including guest of honor, artist Xiao Dong Feng from China.

MEDIA COVERAGE: Northwest Asian Weekly wrote about the reception. Read more…

View the gallery of photos from the symposium and reception here.

 

 

The videos below show the speakers at the symposium:

Dr. Lee Hood and artist Xiao Dong Feng

Dr. Allison Kudla, Communications Designer at Institute for Systems Biology

Dr. Edward Shanken, visiting Associate Professor at University of Washington DXARTS

Moira Scott Payne, Provost and VP for Academic Affairs, Cornish College of the Arts:

Recent Articles

  • Co-corresponding author and ISB President Dr. Jim Heath and co-lead author Dr. Yapeng Su.

    For Cancer Cells, There Is More Than One Path to Drug Resistance

    In findings published in the journal Nature Communications, researchers show that cancer cells can take more than one path to reach a drug-resistant cell state. These findings could have promising implications for the future of cancer care.

  • ISB researchers

    Unveiling the Guerrilla Warfare Tactics of Mycobacterium Tuberculosis

    ISB researchers have unveiled new insights on how Mycobacterium tuberculosis, the pathogen that causes tuberculosis, enters and exits a dormant state in human hosts. About a quarter of the world’s population has latent TB, so these important findings will enable and accelerate the discovery of more effective TB drugs.

  • Merck and ISB Collaborate to Understand and Treat SARS-CoV-2 Infection

    Merck is collaborating with ISB and its partners to analyze blood samples and nasal swabs from Swedish Medical Center patients with SARS-CoV-2. Blood samples will be examined using proteomic, metabolomic, transcriptomics and genetic techniques to evaluate the impact of infection on different organs, and to identify potential biomarkers to predict the risk of severe disease.